" I was appointed as CEO of Todos primarily to he
Post# of 30028
(Total Views: 332)
Posted On: 02/09/2020 3:24:43 PM
" I was appointed as CEO of Todos primarily to help Todos implement its plans to bring its blood testing technologies into the US market and list its common stock onto a US national stock exchange, which would ultimately create substantial value for Amarantus as a significant shareholder in Todos. As part of this initiative, we are working to complete the all-stock acquisition of Amarantus’ subsidiary Breakthrough Diagnostics into Todos Medical in the near future."
https://www.amarantus.com/news/press-releases...areholders
And in the Hempori deal this is mentioned
Under the terms of the agreement, Amarantus is issuing 25 million shares to Hempori in exchange for 51% of the outstanding shares of Hempori, and was granted an option to acquire the remaining shares from the existing shareholders until December 31, 2020 for additional common stock of Amarantus,
* or of a successor entity in the event Amarantus is acquired prior to year-end 2020. Hempori generated over $350,000 from its 2 storefronts in fiscal year 2019.
https://www.amarantus.com/news/press-releases...d-wellness
Aloha
https://www.amarantus.com/news/press-releases...areholders
And in the Hempori deal this is mentioned
Under the terms of the agreement, Amarantus is issuing 25 million shares to Hempori in exchange for 51% of the outstanding shares of Hempori, and was granted an option to acquire the remaining shares from the existing shareholders until December 31, 2020 for additional common stock of Amarantus,
* or of a successor entity in the event Amarantus is acquired prior to year-end 2020. Hempori generated over $350,000 from its 2 storefronts in fiscal year 2019.
https://www.amarantus.com/news/press-releases...d-wellness
Aloha
(2)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼